These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18797198)

  • 61. Gait characteristics of children and youth with chemotherapy induced peripheral neuropathy following treatment for acute lymphoblastic leukemia.
    Wright MJ; Twose DM; Gorter JW
    Gait Posture; 2017 Oct; 58():139-145. PubMed ID: 28779719
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease.
    Dickerhoff R; Lindner W; Scheiber W
    Pediatr Hematol Oncol; 1988; 5(1):61-4. PubMed ID: 3152952
    [No Abstract]   [Full Text] [Related]  

  • 63. Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
    Papadopoulos A; Ntaios G; Kaiafa G; Girtovitis F; Saouli Z; Kontoninas Z; Diamantidis MD; Savopoulos C; Hatzitolios A
    Int J Hematol; 2008 Nov; 88(4):441-442. PubMed ID: 18839274
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nerve lesions after therapy for childhood acute lymphoblastic leukemia.
    Harila-Saari AH; Vainionpää LK; Kovala TT; Tolonen EU; Lanning BM
    Cancer; 1998 Jan; 82(1):200-7. PubMed ID: 9428498
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nasolacrimal system obstruction, ptosis and esotropia due to chemotherapy in acute lymphoblastic leukemia.
    Esmer O; Karadag R; Soylu E; Oner AF; Burakgazi-Dalkilic E
    Cutan Ocul Toxicol; 2013 Oct; 32(4):330-2. PubMed ID: 23461596
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Syndrome of inappropriate secretion of antidiuretic hormone in a patient with myeloid antigen positive acute lymphoblastic leukemia after systemic chemotherapy including vincristine].
    Yoshida M; Ogawa K; Sakamoto H; Motomura S; Ishigatsubo Y
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):99-102. PubMed ID: 10660739
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vincristine neurotoxicity in Charcot-Marie-Tooth syndrome.
    Griffiths JD; Stark RJ; Ding JC; Cooper IA
    Med J Aust; 1985 Sep; 143(7):305-6. PubMed ID: 4046919
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I.
    McGuire SA; Gospe SM; Dahl G
    Med Pediatr Oncol; 1989; 17(6):520-3. PubMed ID: 2685529
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.
    Mercuri E; Poulton J; Buck J; Broadbent V; Bamford M; Jungbluth H; Manzur AY; Muntoni F
    Arch Dis Child; 1999 Nov; 81(5):442-3. PubMed ID: 10519723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comprehensive evaluation of the variation in ankle function during gait in children and youth with Charcot-Marie-Tooth disease.
    Õunpuu S; Garibay E; Solomito M; Bell K; Pierz K; Thomson J; Acsadi G; DeLuca P
    Gait Posture; 2013 Sep; 38(4):900-6. PubMed ID: 23702343
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Current approaches to the treatment of lymphoblastic leukemia in children].
    Makhonova LA; Maiakova SA
    Pediatriia; 1980; (5):22-6. PubMed ID: 6930628
    [No Abstract]   [Full Text] [Related]  

  • 72. Half-and-half nails in a pediatric patient after chemotherapy.
    Afsar FS; Ozek G; Vergin C
    Cutan Ocul Toxicol; 2015; 34(4):350-1. PubMed ID: 25597374
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Results of 16-year use of the 06-Paris-LA-66 program in the treatment of children with acute lymphoblastic leukemia].
    Mendeleev IM; Kovrigina TI; Polezhaev IuN
    Gematol Transfuziol; 1991 Jan; 36(1):23-5. PubMed ID: 2065941
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
    Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatic dysfunction as the presenting feature of acute lymphoblastic leukemia.
    Kelleher JF; Monteleone PM; Steele DA; Gang DL; Angelides AG
    J Pediatr Hematol Oncol; 2001 Feb; 23(2):117-21. PubMed ID: 11216703
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Critical illness polyneuropathy after Bacillus cereus sepsis in acute lymphoblastic leukemia.
    Nishikawa T; Okamoto Y; Tanabe T; Kodama Y; Shinkoda Y; Kawano Y
    Intern Med; 2009; 48(13):1175-7. PubMed ID: 19571454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease.
    Aghajan Y; Yoon JM; Crawford JR
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28438772
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia.
    Gutierrez-Camino Á; Umerez M; Martin-Guerrero I; García de Andoin N; Santos B; Sastre A; Echebarria-Barona A; Astigarraga I; Navajas A; Garcia-Orad A
    Pharmacogenomics J; 2018 Dec; 18(6):704-712. PubMed ID: 29282364
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Successful treatment of acute leukemia with t(4;11) in an infant with congenital hypothyroidism.
    Tonouchi T; Mimaya J; Toyoda Y; Kaneko Y; Kawai S; Ueda R; Kondo M
    Am J Pediatr Hematol Oncol; 1990; 12(3):325-30. PubMed ID: 2240480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.